HRT Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-377,431
| Closed | -$15.4M | – | 3155 |
|
2024
Q2 | $15.4M | Buy |
377,431
+320,816
| +567% | +$13.1M | 0.09% | 173 |
|
2024
Q1 | $2.39M | Sell |
56,615
-25,711
| -31% | -$1.09M | 0.01% | 487 |
|
2023
Q4 | $3.49M | Buy |
+82,326
| New | +$3.49M | 0.03% | 401 |
|
2022
Q1 | – | Sell |
-29,088
| Closed | -$943K | – | 3723 |
|
2021
Q4 | $943K | Buy |
+29,088
| New | +$943K | 0.01% | 1053 |
|
2021
Q2 | – | Sell |
-33,368
| Closed | -$458K | – | 3475 |
|
2021
Q1 | $458K | Buy |
+33,368
| New | +$458K | ﹤0.01% | 1668 |
|